Giuseppe Basso

Q: What Schools Are Affiliated With Giuseppe Basso

Giuseppe Basso is affiliated with the following schools: University of Catania, Humboldt University of Berlin, University of Milan, Hannover Medical School, Stanford University, University of Padua, University of Bologna

Giuseppe Basso's AcademicInfluence.com Rankings

Giuseppe Basso

Computer Science

#6122

World Rank

#6453

Historical Rank

Machine Learning

#1884

World Rank

#1909

Historical Rank

Artificial Intelligence

#2132

World Rank

#2168

Historical Rank

Database

#3234

World Rank

#3370

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Giuseppe Basso's Degrees

PhD Computer Science University of Milan
Masters Computer Science University of Milan
Bachelors Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Giuseppe Basso Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giuseppe Basso's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (2012) (1437)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells (2011) (1123)
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia (2007) (880)
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. (2006) (863)
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response (2014) (854)
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. (2010) (825)
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. (2009) (790)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. (2010) (697)
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood (1998) (617)
Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia (2009) (574)
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. (2010) (566)
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia (2007) (474)
Role of TAZ as Mediator of Wnt Signaling (2012) (432)
Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. (2008) (399)
Chronic myelomonocytic leukemia in childhood. A retrospective analysis of 110 cases. (1997) (386)
γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia (2009) (373)
Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. (2000) (363)
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. (2011) (356)
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia (2008) (334)
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias (2011) (321)
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. (2011) (320)
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials (1997) (308)
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL (2013) (296)
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. (2004) (294)
Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma (2010) (275)
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome (2008) (272)
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. (2007) (256)
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. (2009) (252)
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) (1997) (238)
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. (1998) (231)
SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors (2012) (221)
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia. (2013) (218)
Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. (2011) (217)
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. (2016) (194)
GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. (2005) (191)
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases (1998) (187)
Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. (2005) (184)
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. (2014) (181)
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. (2005) (180)
Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: A CoQ10-responsive condition (2005) (177)
Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ (2016) (171)
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options (2015) (171)
The genetic basis and cell of origin of mixed phenotype acute leukaemia (2018) (171)
MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma (2011) (170)
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia (2010) (167)
Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder (2003) (167)
Large‐Cell Medulloblastomas: A Distinct Variant with Highly Aggressive Behavior (1992) (158)
Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma (2007) (157)
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase (2008) (156)
Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. (2013) (156)
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia (2016) (154)
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting (2007) (149)
Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes (2007) (147)
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis (2017) (146)
Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting. (2013) (145)
Interaction of Hypoxia‐Inducible Factor‐1α and Notch Signaling Regulates Medulloblastoma Precursor Proliferation and Fate (2010) (145)
Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible (2008) (143)
Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues. (2010) (143)
Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. (2003) (141)
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection (2005) (141)
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol (2009) (140)
Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7 (1999) (138)
The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects. (2008) (131)
miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. (2009) (128)
WT1 mutations in T-ALL. (2009) (127)
Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. (1996) (126)
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. (2011) (124)
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. (1999) (123)
CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype. (2013) (121)
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy. (2008) (121)
BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression (2012) (120)
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement (2007) (118)
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. (1997) (117)
IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. (2018) (117)
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. (2003) (117)
Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group. (1992) (113)
c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells. (1998) (113)
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts (2013) (111)
Italian cancer figures, report 2012: Cancer in children and adolescents. (2013) (111)
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. (1995) (110)
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts (2014) (110)
New methodologic approaches for immunophenotyping acute leukemias. (2001) (108)
Genetic loss of SH2B3 in acute lymphoblastic leukemia. (2013) (107)
Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity. (2012) (106)
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia (2017) (105)
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982–1995 (2000) (103)
MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells. (2012) (99)
RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. (2016) (99)
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia (2012) (98)
Detection of minimal residual disease in pediatric acute lymphoblastic leukemia (2013) (97)
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II. (2002) (97)
Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia (2009) (97)
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia (2012) (96)
N-MYC and C-MYC Oncogenes Amplification in Medulloblastomas. Evidence of Particularly Aggressive Behavior of a Tumor with C-MYC Amplification (1991) (96)
Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. (1998) (95)
Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. (1993) (95)
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group. (1997) (93)
CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease (2004) (93)
Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic‐optic chiasm region (1997) (92)
Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways. (2011) (92)
Cytochemical Study of Thymocytes and T Lymphocytes (1980) (90)
Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias. (1995) (89)
Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia (1987) (88)
Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols (2005) (88)
Good steroid response in vivo predicts a favorable outcome in children with T‐cell acute lymphoblastic leukemia (1995) (88)
AIEOP‐BFM Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia (2018) (86)
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome (2004) (86)
Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. (2002) (86)
Lymphocytes subsets reference values in childhood (2015) (85)
Somatic PTPN11 mutations in childhood acute myeloid leukaemia (2005) (85)
Clonal evolution mechanisms in NT5C2 mutant relapsed acute lymphoblastic leukemia (2017) (84)
Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis. (2016) (84)
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups. (1997) (84)
Hypoxia and HIF1α Repress the Differentiative Effects of BMPs in High‐Grade Glioma (2009) (83)
Convergent synthesis and biological evaluation of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as microtubule targeting agents. (2011) (82)
Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. (1992) (81)
LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia (2015) (78)
The Three-Layer Concentric Model of Glioblastoma: Cancer Stem Cells, Microenvironmental Regulation, and Therapeutic Implications (2011) (78)
Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification (2000) (78)
Isoindolo[2,1-a]quinoxaline derivatives, novel potent antitumor agents with dual inhibition of tubulin polymerization and topoisomerase I. (2008) (78)
Minimal residual disease is an important predictive factor of outcome in children with relapsed ‘high-risk’ acute lymphoblastic leukemia (2008) (77)
Modulation of antigen expression in B‐cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: Evidence for a drug‐induced regulatory phenomenon. Results of the AIEOP‐BFM‐ALL‐FLOW‐MRD‐Study Group (2010) (76)
Gamma-secretase inhibitors reverse glucocorticoid resistance in T-ALL (2008) (74)
Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. (2010) (74)
Genomic subtyping and therapeutic targeting of acute erythroleukemia (2019) (73)
Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks (2009) (73)
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. (2008) (72)
Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker (2004) (72)
Analysis of cyclin‐dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma (1996) (71)
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study. (2014) (71)
Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia. (2003) (70)
Synthesis and biological evaluation of 2-(alkoxycarbonyl)-3-anilinobenzo[b]thiophenes and thieno[2,3-b]pyridines as new potent anticancer agents. (2013) (69)
Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome. (2013) (69)
Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition. (2011) (68)
Determination of extracellular and intracellular pH of Bacillus subtilis suspension under CO2 treatment. (2005) (68)
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? (2013) (68)
A mesenchymal chondrosarcoma of a child with the reciprocal translocation (11;22)(q24;q12). (1993) (67)
JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis (2014) (66)
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. (1998) (65)
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction (2009) (65)
Wnt activation promotes neuronal differentiation of Glioblastoma (2013) (65)
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. (2018) (63)
Flow cytometry: its applications in hematology. (1995) (63)
Perceived social support and health‐related quality of life in AYA cancer survivors and controls (2016) (62)
Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B‐cell precursor acute lymphoblastic leukemia cells (2008) (60)
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model (2011) (60)
Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia (2015) (59)
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia (2018) (59)
Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). (1994) (58)
Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells (2011) (57)
Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors. (1994) (57)
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis (2014) (57)
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 (2010) (57)
The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. (2012) (57)
Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). (2017) (57)
Loss‐of‐function JAK3 mutations in TMD and AMKL of Down syndrome (2007) (56)
Recent advances in vascular disrupting agents in cancer therapy. (2014) (56)
Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica. (2001) (55)
Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients (2009) (54)
Rearrangement of CRLF 2 in B-progenitor – and Down syndrome – associated acute lymphoblastic leukemia (2009) (54)
Discovery and optimization of a series of 2-aryl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazoles as novel anticancer agents. (2012) (53)
Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations (2014) (53)
Synthesis and biological evaluation of 2-substituted-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as anticancer agents. (2012) (53)
Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma (1997) (53)
The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicentre study (AIEOP) (1992) (51)
Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification (2003) (51)
p53 Gene Mutations in Medulloblastoma: Immunohistochemistry Gel Shift Analysis, and Sequencing (1993) (50)
Prognostic significance of flow‐cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP‐AML 2002/01 study protocol (2017) (50)
Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring (2003) (50)
2-Arylamino-4-amino-5-aroylthiazoles. "One-pot" synthesis and biological evaluation of a new class of inhibitors of tubulin polymerization. (2009) (49)
Individual and combined effect of granulocyte–macrophage colony‐stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum‐free conditions (2000) (49)
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles (2011) (49)
Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells (2014) (49)
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies (2018) (49)
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia. (2017) (48)
Functional characterization of human COQ4, a gene required for Coenzyme Q10 biosynthesis. (2008) (48)
Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas. (1993) (48)
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia. (2016) (48)
Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study (2013) (48)
Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements (2005) (48)
Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles. (2014) (47)
Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL (2010) (47)
Large and Dissimilar Repertoire of Melan-A/MART-1-Specific CTL in Metastatic Lesions and Blood of a Melanoma Patient1 (2002) (47)
Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma. (2010) (47)
Dexamethasone in Induction Can Eliminate One Third of All Relapses in Childhood Acute Lymphoblastic Leukemia (ALL): Results of An International Randomized Trial in 3655 Patients (Trial AIEOP-BFM ALL 2000) (2008) (47)
T‐cell lymphoblastic lymphoma shows differences and similarities with T‐cell acute lymphoblastic leukemia by genomic and gene expression analyses (2011) (47)
Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene (2007) (47)
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study. (2019) (47)
Stem cell factor suppresses apoptosis in neuroblastoma cell lines. (1997) (46)
The COQ2 genotype predicts the severity of coenzyme Q10 deficiency. (2016) (46)
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement (2014) (46)
Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations. (2014) (45)
Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations (2014) (45)
cAMP response element binding protein (CREB) overexpression CREB has been described as critical for leukemia progression (2007) (44)
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL (2002) (44)
Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia (1998) (44)
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin. (2015) (44)
Molecular Mechanisms of HIF-1α Modulation Induced by Oxygen Tension and BMP2 in Glioblastoma Derived Cells (2009) (43)
Apoptosis and phosphatidylserine-mediated recognition during the take-over phase of the colonial life-cycle in the ascidian Botryllus schlosseri (2003) (43)
Wnt activation promotes neuronal differentiation of Glioblastoma (2013) (43)
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures (2009) (43)
Pre‐ and post‐transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia (2018) (43)
Acute lymphoblastic leukemia and Down syndrome (2008) (42)
Haemocytes and blastogenetic cycle in the colonial ascidian Botryllus schlosseri: a matter of life and death (2008) (42)
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. (2010) (42)
Central role of mitochondria and p53 in PUVA-induced apoptosis in human keratinocytes cell line NCTC-2544. (2008) (42)
Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluation. (2009) (41)
MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation (2013) (41)
Characterization of two patients with lymphomas of large granular lymphocytes (1984) (41)
Concise synthesis and biological evaluation of 2-Aroyl-5-amino benzo[b]thiophene derivatives as a novel class of potent antimitotic agents. (2013) (40)
Co‐expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance (1991) (40)
Phf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-ALL. (2018) (40)
Pyrrolo[3,4-h]quinolinones a new class of photochemotherapeutic agents. (2011) (40)
BAG1: The Guardian of Anti-Apoptotic Proteins in Acute Myeloid Leukemia (2011) (40)
Proapoptotic effect of hepatitis C virus CORE protein in transiently transfected cells is enhanced by nuclear localization and is dependent on PKR activation. (2004) (40)
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy. (2018) (39)
PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis (2017) (39)
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells (2013) (39)
Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood. (2007) (39)
Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA. (2000) (39)
Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). (1998) (39)
MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia. (2014) (39)
The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occurring in children with Down syndrome (1997) (39)
Coagulation Activation in Children with Sickle Cell Disease Is Associated with Cerebral Small Vessel Vasculopathy (2013) (38)
Immunogenotype Changes Prevail in Relapses of Young Children with TEL-AML1-Positive Acute Lymphoblastic Leukemia and Derive Mainly from Clonal Selection (2005) (38)
Cytogenetic analysis of hepatoblastoma: hypothesis of cytogenetic evolution in such tumors and results of a multicentric study. (1998) (38)
Transient acute monoblastic leukemia with reciprocal (8;16)(p11;p13) translocation. (1996) (37)
Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group (2015) (37)
Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymomas? (1992) (37)
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias (2011) (36)
Clinical and biological significance of CD34 expression in acute leukemia. (2001) (36)
Induction of gamma-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocumarin derivatives. (2008) (36)
Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma (1998) (36)
Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma. (2007) (36)
Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles (2016) (36)
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response (2002) (36)
Natural daucane sesquiterpenes with antiproliferative and proapoptotic activity against human tumor cells. (2011) (36)
A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia. (2005) (36)
Post-traumatic Stress Symptoms and Post-traumatic Growth in 223 Childhood Cancer Survivors: Predictive Risk Factors (2016) (36)
Mutations of JAK 2 in acute lymphoblastic leukaemias associated with Down ’ s syndrome (2008) (36)
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene (2017) (35)
High incidence and unique features of antigen receptor gene rearrangements in TEL–AML1-positive leukemias (2004) (35)
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agents. (2010) (35)
Chemokine receptor expression and function in childhood acute lymphoblastic leukemia of B-lineage. (2006) (35)
Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B‐Cell Lymphoma treated with the AIEOP LNH‐97 protocol (2016) (35)
Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia (1997) (35)
MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study (2011) (35)
Cell Adhesion Molecule Expression in Cord Blood CD34+ Cells (1998) (35)
Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia. (1995) (34)
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis (2015) (33)
Annexin 2A sustains glioblastoma cell dissemination and proliferation (2016) (33)
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. (2019) (33)
Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience (2015) (33)
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis (2013) (33)
Design, synthesis and biological evaluation of 3,5-disubstituted 2-amino thiophene derivatives as a novel class of antitumor agents. (2014) (33)
Cytogenetics of pediatric central nervous system tumors. (1996) (33)
Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction (2013) (33)
Hovering between death and life: natural apoptosis and phagocytes in the blastogenetic cycle of the colonial ascidian Botryllus schlosseri. (2010) (32)
Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors. (2013) (32)
The role of immunophenotype in acute lymphoblastic leukemia of infant age. (1994) (32)
Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement (2015) (32)
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia (2013) (32)
Characterization and transcription studies of a phytochelatin synthase gene from the solitary tunicate Ciona intestinalis exposed to cadmium. (2014) (32)
Copper and bezafibrate cooperate to rescue cytochrome c oxidase deficiency in cells of patients with sco2 mutations (2012) (32)
Tubulointerstitial responses in the progression of glomerular diseases: Albuminuria modulates αvβ5 integrin (1996) (32)
Functional Complementation in Yeast Allows Molecular Characterization of Missense Argininosuccinate Lyase Mutations* (2009) (31)
Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project (2011) (31)
MGMT expression and promoter methylation status may depend on the site of surgical sample collection within glioblastoma: a possible pitfall in stratification of patients? (2011) (31)
Hematopoietic stem cell transplantation for children with high-risk acute lymphoblastic leukemia in first complete remission: a report from the AIEOP registry (2013) (30)
Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: effects of CREB pathway inhibition. (2014) (30)
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. (2006) (29)
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group (2017) (29)
Comprehensive care for sickle cell disease immigrant patients: A reproducible model achieving high adherence to minimum standards of care (2012) (29)
Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children (2014) (29)
One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agent. (2011) (29)
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling (2015) (29)
Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88. (1997) (28)
Vanillic Acid Restores Coenzyme Q Biosynthesis and ATP Production in Human Cells Lacking COQ6 (2019) (28)
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols (2019) (28)
Detection and role of minimal disseminated disease in children with lymphoblastic lymphoma: The AIEOP experience (2015) (28)
Health‐related quality of life in AYA cancer survivors who underwent HSCT compared with healthy peers (2018) (28)
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP‐BFM ALL protocols (2018) (28)
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol (2015) (27)
AKR1C enzymes sustain therapy resistance in paediatric T-ALL (2018) (27)
ICER expression inhibits leukemia phenotype and controls tumor progression (2008) (27)
The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line. (2006) (27)
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia (2019) (27)
Treosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease (2017) (26)
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment (2016) (26)
Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia. (2014) (26)
Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing. (2018) (26)
Effects of CD2 locus control region sequences on gene expression by retroviral and lentiviral vectors. (2001) (26)
Latent hepatitis B virus infection in childhood hepatocellular carcinoma analysis by polymerase chain reaction (1992) (26)
Self-Esteem and Academic Difficulties in Preadolescents and Adolescents Healed from Paediatric Leukaemia (2017) (26)
Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology. (2008) (26)
hCOX18 and hCOX19: two human genes involved in cytochrome c oxidase assembly. (2005) (26)
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints (2015) (26)
A NOVEL VARIANT TRANSLOCATION t(2;13) (p23;q34) IN Ki‐1 LARGE CELL ANAPLASTIC LYMPHOMA (1990) (26)
Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children (2015) (26)
CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia (2019) (26)
Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy (1998) (25)
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia (2015) (25)
DLX genes as targets of ALL‐1: DLX 2,3,4 down‐regulation in t(4;11) acute lymphoblastic leukemias (2003) (25)
Immunohistochemical distribution of endothelin in biopsies of pediatric nephrotic syndrome. (1994) (25)
Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals (2019) (25)
NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group (2017) (25)
The phototoxicity of fluvastatin, an HMG-CoA reductase inhibitor, is mediated by the formation of a benzocarbazole-like photoproduct. (2010) (25)
Increased levels of a chromosome 21‐encoded tumour invasion and metastasis factor (TIAM1) mRNA in bone marrow of down syndrome children during the acute phase of AML(M7) (1998) (25)
Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa (2013) (25)
Therapeutic Effectiveness of Recombinant Cancer Vaccines Is Associated with a Prevalent T-Cell Receptor α Usage by Melanoma-specific CD8+ T Lymphocytes (2004) (25)
Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation. (2007) (24)
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia (2013) (24)
BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma (2018) (24)
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis (2016) (24)
Methylation of the IL-12Rβ2 Gene as Novel Tumor Escape Mechanism for Pediatric B-Acute Lymphoblastic Leukemia Cells (2006) (24)
HAIRY CELL LEUKAEMIA WITH T CELL FEATURES (1980) (24)
Identification of somatic and germline mutations using whole exome sequencing of congenital acute lymphoblastic leukemia (2013) (24)
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole (2016) (24)
Unique genotypic features of infant acute lymphoblastic leukaemia at presentation and at relapse (1992) (24)
Phenotypic and functional characterization of Glioblastoma cancer stem cells identified trough 5-aminolevulinic acid-assisted surgery (2014) (24)
Risk‐directed therapy for childhood acute lymphoblastic leukemia. Results of the associazione italiana ematologia oncologia pediatrica '82 studies (1993) (24)
Functional Analysis of Missense Mutations of OAT, Causing Gyrate Atrophy of Choroid and Retina (2013) (24)
New Pyrimido-Indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects without Cardiotoxicity (2015) (24)
COX16 is required for assembly of cytochrome c oxidase in human cells and is involved in copper delivery to COX2. (2018) (23)
Advanced pediatric myelodysplastic syndromes: Can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool? (2009) (23)
The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia (2005) (23)
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL (2017) (23)
Flt-3 and Its Ligand Are Expressed in Neural Crest–Derived Tumors and Promote Survival and Proliferation of Their Cell Lines (2001) (23)
Expression of CD 58 in normal , regenerating and leukemic bone marrow B cells : implications for the detection of minimal residual disease in acute lymphocytic leukemia (2003) (23)
TP‐0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy (2018) (23)
Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition. (2004) (23)
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia (2013) (23)
A novel copper(I) complex induces ER-stress-mediated apoptosis and sensitizes B-acute lymphoblastic leukemia cells to chemotherapeutic agents (2014) (23)
Intellectual function evaluation of first generation immigrant children with sickle cell disease: the role of language and sociodemographic factors (2013) (22)
Photophysical Properties and Photobiological Behavior of Amodiaquine, Primaquine and Chloroquine (2007) (22)
HIF-1α/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells (2019) (22)
CREB engages C/EBPδ to initiate leukemogenesis (2016) (22)
Long‐term results of the AIEOP LNH‐97 protocol for childhood lymphoblastic lymphoma (2015) (22)
Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B‐acute lymphoblastic leukemia (B‐All) (2018) (22)
Natural daucane esters induces apoptosis in leukaemic cells through ROS production. (2014) (22)
Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia (2011) (22)
Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI Study (2016) (22)
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia (2014) (22)
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia (2020) (22)
Recommended reporting format for flow cytometry diagnosis of acute leukemia. (2004) (22)
Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells (2015) (22)
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort (2015) (22)
Hepatocyte Growth Factor Receptor c-MET Is Associated with FAS and When Activated Enhances Drug-induced Apoptosis in Pediatric B Acute Lymphoblastic Leukemia with TEL-AML1 Translocation* (2007) (22)
Induction of apoptosis in Jurkat cells by photoexcited psoralen derivatives: Implication of mitochondrial dysfunctions and caspases activation. (2007) (22)
Induction of apoptosis by photoexcited tetracyclic compounds derivatives of benzo[b]thiophenes and pyridines. (2006) (21)
Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing (2016) (21)
p53 gene inactivation in acute lymphoblastic leukemia of B cell lineage associates with chromosomal breakpoints at 11q23 and 8q24. (1995) (21)
Pitavastatin, a new HMG-CoA reductase inhibitor, induces phototoxicity in human keratinocytes NCTC-2544 through the formation of benzophenanthridine-like photoproducts (2012) (21)
PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA. A PROSPECTIVE STUDY OF THE INTERNATIONL BFM STUDY GROUP. (1998) (21)
Screening of novel genetic aberrations in pediatric acute myeloid leukemia: a report from the AIEOP AML-2002 study group. (2012) (21)
Distribution of TP53 mutations among acute leukemias with MLL rearrangements (1996) (21)
FOXO3a and Posttranslational Modifications Mediate Glucocorticoid Sensitivity in B-ALL (2015) (21)
Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative Activity. (2015) (21)
Eltrombopag use in a patient with Wiskott–Aldrich syndrome (2017) (21)
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1) (2016) (21)
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. (2013) (20)
Fluorescent in situ hybridization (FISH) reveals frequent and recurrent numerical and structural abnormalities in hepatoblastoma with no informative karyotype. (2002) (20)
Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL). (1994) (20)
Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome. (1996) (20)
Low PKCa expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome (2014) (20)
Recurrent phagocytosis-induced apoptosis in the cyclical generation change of the compound ascidian Botryllus schlosseri. (2016) (20)
Cognitive evoked potentials and neural networks are abnormal in children with sickle cell disease and not related to the degree of anaemia, pain and silent infarcts (2015) (20)
The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group (2008) (20)
Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study. (2001) (20)
A synthetic BMP-2 mimicking peptide induces glioblastoma stem cell differentiation. (2017) (20)
Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axis (2018) (19)
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia (2017) (19)
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells. (2018) (19)
A single high dose of idarubicin combined with high‐dose ARA‐C for treatment of first relapse in childhood ‘high‐risk’ acute lymphoblastic leukaemia: a study of the AIEOP group (2002) (19)
EB‐3D a novel choline kinase inhibitor induces deregulation of the AMPK‐mTOR pathway and apoptosis in leukemia T‐cells (2018) (19)
FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs (2014) (19)
Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia. (1994) (19)
Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia (2015) (19)
CD11b is a therapy resistance- and minimal residual disease-specific marker in precursor B-cell acute lymphoblastic leukemia. (2010) (19)
Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group (2016) (19)
Unusual leukemic presentation of rhabdomyosarcoma: report of two cases with immunological, ultrastructural and cytogenetical studies. (1991) (18)
Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours (2019) (18)
Molecular and immunological evidence of B‐cell commitment in “null” acute lymphoblastic leukaemia (1986) (18)
A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction (2015) (18)
Risk Factors and Outcomes Related to Pediatric Intensive Care Unit Admission after Hematopoietic Stem Cell Transplantation: A Single-Center Experience. (2017) (18)
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study. (2005) (18)
Expression of type I interferon receptor in solid tumors of childhood. (1997) (18)
Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy Approach (2016) (18)
Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. (2012) (17)
Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome. (2005) (17)
Vascular disrupting activity of combretastatin analogues. (2016) (17)
Synthesis and in vitro Evaluation of 3H‐Pyrrolo[3,2‐f]quinolin‐9‐one Derivatives That Show Potent and Selective Anti‐leukemic Activity (2010) (17)
PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy (2010) (17)
Design, synthesis and biological evaluation of arylcinnamide hybrid derivatives as novel anticancer agents. (2014) (17)
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups (2014) (17)
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma (2018) (17)
Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia. (2006) (17)
Differential response of linear and angular psoralens in PUVA-induced apoptosis in HL-60 cells. (2004) (17)
Diagnosis and genetic subtypes of leukemia combining gene expression and flow cytometry. (2007) (17)
Somatic mutations activating Wiskott–Aldrich syndrome protein concomitant with RAS pathway mutations in juvenile myelomonocytic leukemia patients (2018) (16)
Synthesis and photochemotherapeutic activity of thiopyrano[2,3-e]indol-2-ones. (2005) (16)
Adolescent and young adult cancer survivors narrate their stories: Predictive model of their personal growth and their follow-up acceptance. (2018) (16)
Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica (AIEOP). (1993) (16)
Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury. (2017) (16)
Calcineurin and GSK-3 inhibition sensitizes T-cell acute lymphoblastic leukemia cells to apoptosis through X-linked inhibitor of apoptosis protein degradation (2016) (16)
Whole transcriptome sequencing of a paediatric case of de novo acute myeloid leukaemia with del(5q) reveals RUNX1‐USP42 and PRDM16‐SKI fusion transcripts (2014) (16)
CD4+ T regulatory cells are more resistant to DNA damage compared to CD4+ T effector cells as revealed by flow cytometric analysis (2011) (16)
Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL (2018) (16)
The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity (2009) (16)
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients (2015) (16)
Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial (2015) (16)
Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma (2016) (16)
Interleukin-2 before and/or after autologous bone marrow transplantation for pediatric acute leukemia patients. (1996) (16)
Synthesis and Biological Evaluation of New Geiparvarin Derivatives (2009) (16)
Motor skill delays in pre-school children with leukemia one year after treatment: Hematopoietic stem cell transplantation therapy as an important risk factor (2017) (16)
Molecular characterization of a new recombination of the SIL/TAL‐1 locus in a child with T‐cell acute lymphoblastic leukaemia (2002) (15)
Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia (2016) (15)
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia. (2014) (15)
The effect of cytokines, including IL4, IL7, stem cell factor, insulin-like growth factor on childhood acute lymphoblastic leukemia. (1997) (15)
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents. (2017) (15)
LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursors (2019) (15)
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to “Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute ly (2013) (15)
Posttranslational regulation of the exon skipping machinery controls aberrant splicing in leukemia. (2020) (15)
Low prevalence of IDH1 gene mutation in childhood AML in Italy (2011) (15)
Flow‐cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B‐cell precursor acute lymphoblastic leukemia in trial AIEOP‐BFM‐ALL 2000 (2019) (15)
Diazoniapolycyclic Ions Inhibit the Activity of Topoisomerase I and the Growth of Certain Tumor Cell Lines (2008) (15)
New data on robustness of gene expression signatures in leukemia: comparison of three distinct total RNA preparation procedures (2007) (15)
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML (2018) (15)
Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling. (2014) (15)
Patient Satisfaction in Italian Childhood Cancer Survivors: Human Aspects of Treatment as a Key Factor in Patients' Quality of Life (2015) (15)
Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia (2021) (14)
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report (2021) (14)
Synthesis, Cytotoxicity, and Apoptosis Induction in Human Tumor Cells by Geiparvarin Analogues (2004) (14)
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial (2019) (14)
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1. (2015) (14)
Psychopathological Aspects in Childhood Hematopoietic Stem Cell Transplantation (HSCT): The Perception of Parents and Adolescents (2017) (14)
Flow diagnostics essential code: A simple and brief format for the summary of leukemia phenotyping (2014) (14)
Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma (2017) (14)
DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study (2011) (14)
Microsatellite analysis in childhood acute lymphoblastic leukemia. (1998) (14)
Novel 9'-substituted-noscapines: synthesis with Suzuki cross-coupling, structure elucidation and biological evaluation. (2014) (14)
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins (2016) (14)
Non‐Hodgkin lymphoma in children with an associated inherited condition: A retrospective analysis of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) (2015) (13)
Isolation and expansion of regionally defined human glioblastoma cells in vitro. (2011) (13)
Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors (2015) (13)
Expression and Distribution of the Adrenomedullin System in Newborn Human Thymus (2014) (13)
Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols (2020) (13)
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action (2019) (13)
Hematopoietic stem cell transplantation for isolated extramedullary relapse of acute lymphoblastic leukemia in children (2018) (13)
Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia. (1998) (13)
Active and late rosette-forming cells: immunological and cytochemical characterization. (1981) (13)
Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing (2015) (13)
Targeting BAG-1: a novel strategy to increase drug efficacy in acute myeloid leukemia. (2015) (13)
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia (2003) (13)
Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents. (2017) (13)
ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia (2017) (13)
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents (2017) (13)
Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene (1997) (13)
Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia. (2012) (13)
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. (2018) (12)
Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classification. (1987) (12)
GIMEMA-AIEOP AIDA Protocols for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) In Children: Analysis of 247 Patients Enrolled In Two Sequential Italian Multicenter Trials (2010) (12)
Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia. (2009) (12)
WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia (2017) (12)
Primary intestinal lymphangiectasia. Comparison between endoscopic and radiological findings. (1980) (12)
Is the deletion of the short arm of chromosome 1 a prognostic factor in pediatric peripheral primitive neuroepithelioma (PNET)? (1996) (12)
ABL proteins in Philadelphia‐positive acute leukaemias and chronic myelogenous leukaemia blast crises (1990) (12)
Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels (2016) (12)
Philadelphia-Like Signature In Childhood Acute Lymphoblastic Leukemia: The AIEOP Experience (2013) (12)
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy (2006) (12)
An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts (2016) (12)
Value of cytogenetics in the differential diagnosis of the small round cell tumors of childhood. (1992) (12)
Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis (2017) (11)
Reduced Intensity Delayed Intensification in Standard-Risk Patients Defined By Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Results of an International Randomized Trial in 1164 Patients (Trial AIEOP-BFM ALL 2000) (2016) (11)
Molecular characterization of Ph' + hybrid acute leukemia. (1989) (11)
Association of cytogenetic abnormalities with detection of BCR‐ABL fusion transcripts in children with T‐lineage lymphoproliferative diseases (T‐ALL and T‐NHL) (2004) (11)
Linking Hepatic Transcriptional Changes to High–Fat Diet Induced Physiology for Diabetes-Prone and Obese-Resistant Mice (2007) (11)
Psychosocial life achievements in adults even if they received prophylactic cranial irradiation for acute lymphoblastic leukemia during childhood (2013) (11)
Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia (2003) (11)
Are genotypes of glutathione S-transferase superfamily a risk factor for childhood acute lymphoblastic leukemia? Results of an Italian case–control study (2007) (11)
Granular acute lymphoblastic leukemia in children. "Aieop Cooperative Group for Cytology of Acute Leukemias". (1992) (11)
A Case of T‐cell Acute Lymphoblastic Leukemia Relapsed As Myeloid Acute Leukemia (2016) (11)
Rapid detection of clonality in patients with acute lymphoblastic leukemia. (2001) (10)
Design of a comprehensive fluorescence in situ hybridization assay for genetic classification of T-cell acute lymphoblastic leukemia. (2020) (10)
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocol. (2018) (10)
Altered mRNA expression of PAX5 is a common event in acute lymphoblastic leukaemia (2009) (10)
Identification of immunophenotypic signatures by clustering analysis in pediatric patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia (2010) (10)
WT 1 mutations in TALL (2009) (10)
Heterogeneity of TdT +, HLA‐DR + acute leukaemia: Immunological, immunocytochemical and clinical evidence of lymphoid and myeloid origin (1987) (10)
Differences in circulating microRNA signature in Prader–Willi syndrome and non-syndromic obesity (2018) (10)
Three novel fusion transcripts of the paired box 5 gene in B-cell precursor acute lymphoblastic leukemia (2015) (10)
L-Proline as a modulator of ectodermal differentiation in ES cells. Focus on "L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture. (2010) (10)
Fluorescence in situ hybridization improves cytogenetic results in the analysis of hepatoblastoma. (2002) (10)
Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Acute Lymphoblastic Leukemia (ALL) According to WBC Count, Age and TEL/AML1 Status at Diagnosis. Results of the AIEOP-BFM ALL 2000 Study. (2007) (9)
A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma (2019) (9)
Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition (2009) (9)
Congenital hypoplastic anaemia developed in acute megakarioblastic leukaemia. A case report. (1981) (9)
NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma (2017) (9)
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation (2016) (9)
Primary mediastinal large B‐cell lymphoma: Outcome of a series of pediatric patients treated with high‐dose methotrexate and cytarabine plus anti‐CD20 (2018) (9)
Does hepatitis B virus play a role in primary liver cancer in children of Western countries? (1991) (9)
The SCF FBW 7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia (2007) (9)
Selective Difficulties in Lexical Retrieval and Nonverbal Executive Functioning in Children With HbSS Sickle Cell Disease (2018) (9)
Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: the experience of the AIEOP Cooperative Study. Associazione Italiana Ematologia Oncologia Pediatrica. (1993) (9)
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia (2022) (8)
Cytokeratins patterns in childhood primary liver tumors (1993) (8)
Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease (2018) (8)
Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates alpha v beta 5 integrin. (1996) (8)
Clinical features of childhood acute myeloid leukaemia with specific gene rearrangements (2004) (8)
Cerebrospinal fluid analysis by 8-color flow cytometry in children with acute lymphoblastic leukemia (2019) (8)
Erratum: Wnt activation promotes neuronal differentiation of Glioblastoma (Cell Death and Disease (2013) 4 (e500) DOI: 10.1038/cddis.2013.32) (2013) (8)
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia (2018) (8)
17q21-qter trisomy is an indicator of poor prognosis in acute myelogenous leukemia. (2001) (8)
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia : insight on prognostic value of DNA index in the framework of Berlin-Frnkfurt-Munster based chemotherapy (2008) (8)
Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia (2012) (8)
The c-kit receptor and its ligand stem cell factor in childhood malignant lymphoid precursors. (1999) (8)
Cytofluorimetric analysis of CD34 cells. (1998) (8)
Longitudinal evaluation of cerebral white matter hyperintensities lesion volume in children with sickle cell disease (2017) (8)
Cytogenetics of infantile leukemias and its correlations with bio-clinical features. The "G. Gaslini" Children's Hospital experience over a 9-year period. (1991) (8)
Karyotype evolution in a patient with biphenotypic neonatal leukemia. (1992) (8)
Genetic characterization and therapeutic targeting of MYC‐rearranged T cell acute lymphoblastic leukaemia (2018) (8)
Ex vivo-expanded bone marrow CD34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. (2011) (8)
Adaptive Functioning of Preschooler Children with Leukemia Post 1 Year of Therapies Compared with Sane Peers (2016) (7)
Expression of the immunoglobulin superfamily cell membrane adhesion molecule Cd146 in acute leukemia (2016) (7)
Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression. (1992) (7)
ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors (2015) (7)
A Multi-Center and Multi-National Program To Assess the Clinical Accuracy of the Molecular Subclassification of Leukemia by Gene Expression Profiling. (2005) (7)
Proteomic Alterations in Response to Hypoxia Inducible Factor 2α in Normoxic Neuroblastoma Cells. (2016) (7)
Low prevalence of IDH1 gene mutation in childhood AML in Italy. Leukemia. (2010) (7)
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells (2022) (7)
Immunological features in chronic lymphocytic leukaemia (CLL) of T cell origin. (1979) (7)
Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overload. (2005) (7)
Acute Leukemia Subclassification: A Marker Protein Expression Perspective (2004) (7)
Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy. AIEOP/FONOP-TMO Group. Italian Association of Paediatric Haemato-Oncology. (1998) (7)
Monoclonal antibody panels for acute leukemia and myelodysplastic syndrome diagnosis. Results of a co-operative quality control group. (2001) (7)
Immunocytochemical evidence of common-ALL antigen in null-ALL. (2009) (7)
Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia Pediatrica. (1998) (7)
Study of cytochemical markers ACP and ANAE in childhood lymphoma and leukaemia. (1980) (7)
Interleukin‐22 in the diagnosis of active chronic graft‐versus‐host disease in paediatric patients (2015) (7)
Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells. (2006) (7)
Attachment orientations and psychological adjustment of parents of children with cancer: A matched-group comparison (2017) (6)
Renal immunohistochemical distribution, plasma levels and urinary excretion of endothelin after kidney transplantation. (1997) (6)
EARLY T-CELL PRECURSOR LEUKEMIA: A SUBTYPE OF VERY HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA IDENTIFIED IN TWO INDEPENDENT COHORTS (2010) (6)
Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia (2006) (6)
Chromosome-Positive ( Ph 1 ) Childhood Acute Lymphoblastic Leukemia : Good Initial Steroid Response Allows Early Prediction of a Favorable Treatment Outcome (1998) (6)
A three‐miRNA‐based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1‐RUNX1T1 acute myeloid leukaemia (2018) (6)
Acute differentiated dendritic cell leukemia: a variant form of pediatric acute myeloid leukemia with MLL translocation (2007) (6)
LIN 28 B overexpression de fi nes a novel fetal-like subgroup of juvenile myelomonocytic leukemia (2016) (6)
The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1plus) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment (2014) (6)
Course of anti‐ALK antibody titres during chemotherapy in children with anaplastic large cell lymphoma (2018) (6)
The effects of siRNA-mediated inhibition of E 2 A-PBX 1 on EB-1 and Wnt 16 b expression in the 697 pre-B leukemia cell (2006) (6)
Can primary cancer of the liver in Western countries be prevented? Pediatric point of view. (1990) (6)
Chronic myelomonocytic leukemia (CMML) in childhood (1994) (6)
D cells with cytotoxic activity in acute lymphoblastic leukemia. (1980) (6)
Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients. (2009) (6)
Non‐T, non‐B childhood acute lymphoblastic leukemia. Correlation between cytochemical markers and first complete remission (1984) (6)
mll ortholog containing functional domains of human MLL is expressed throughout the zebrafish lifespan and in haematopoietic tissues (2011) (6)
Haploidentical TCR A/B and B-cell depleted hematopoietic SCT in pediatric SAA and aspergillosis (2014) (6)
Comparative sequence analysis of incomplete DJH and TCR gene rearrangements in children with relapses of T-ALL (2005) (6)
RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia (2020) (6)
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation (2020) (6)
Collaboration between Activating Mutations in JAK2 and Trisomy 21 in the Acute Lymphoblastic Leukemias of Down Syndrome (DS). (2007) (5)
The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL. (2020) (5)
Parental Narratives of Children with Leukemia in the Second Week after the Diagnosis: The Ecocultural Family Interview-Cancer (2013) (5)
Acute Lymphoblastic Leukemia in Children with Down Syndrome: A Report From the Ponte Di Legno Study Group (2011) (5)
ICER Evokes Dusp1-p38 Pathway Enhancing Chemotherapy Sensitivity in Myeloid Leukemia (2011) (5)
SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric ETV6-RUNX1 B-Acute Lymphoblastic Leukemia Patients (2019) (5)
Rare frequencey of point mutations for codon 12, 13 and 61 of ras gene in italian neuroblastoma. (1993) (5)
Combined cell sorting and FISH for detection of minimal residual disease in bone marrow of children with acute leukemia or solid tumors. (1997) (5)
Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in Italy. AIEOP/FONOP TMO Group (1998) (5)
COPING WITH PAIN IN CHILDREN WITH LEUKEMIA (2015) (5)
CD 11 b is a therapy resistance – and minimal residual disease – specific marker in precursor B-cell acute lymphoblastic leukemia (2010) (5)
Flow cytometric immunophenotyping of acute lymphoblastic leukemia: is the time ready for consensus the guidelines? (2002) (5)
DHH-RHEBL 1 fusion transcript : a novel recurrent feature in the new landscape of pediatric CBFA 2 T 3-GLIS 2-positive acute myeloid leukemia (2013) (4)
Non-medical applications of non-invasive prenatal diagnosis: Ethical issues (2011) (4)
Autosomal dominant macrothrombocytopenia with ineffective thrombopoiesis. (2002) (4)
Flow diagnostics essential (FDE) code: A simple and brief format for the summary of leukemia phenotyping: Flow Diagnostics Essential (FDE) Code (2013) (4)
Early evaluation of bone marrow minimal residual disease by flowcytometry on day 15 is feasible on a multicenter basis and bears strong prognostic value in childhood acute lymphoblastic leukemia. The AIEOP-BFM experience (2007) (4)
Effects of exposure to extremely low frequency electro-magnetic fields on circadian rhythms and distribution of some leukocyte differentiation antigens in dairy cows. (2007) (4)
Hypoxia and HIF1{alpha} repress the differentiative effects of BMPs in high grade glioma. Stem Cells. 2008 Oct 2. [Epub ahead of print] PMID: 18832593 [PubMed - as supplied by publisher] (2008) (4)
Digital-Droplet PCR, an Accurate Method for IG/TR PCR-MRD Stratification in Childhood Acute Lymphoblastic Leukemia (2018) (4)
Time Point-Dependent Concordance of Flow Cytometry and RQ-PCR in the MRD Detection in Childhood ALL: The Experience of the AIEOP-BFM- ALL MRD Study Group (2008) (4)
CD56, HLA‐DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3‐GLIS2 fusion transcript (2021) (4)
Peculiar allelotype associated with susceptibility to neuroblastoma (1996) (4)
Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse? (2002) (4)
Bone marrow ectopic expression of a non-coding RNA in childhood T-cell acute lymphoblastic leukemia with a novel t(2;11)(q11.2;p15.1) translocation (2008) (4)
Cytochemical study in human lymphocyte subpopulations as defined by Fc receptors. (1981) (4)
Children with TEL/AML1-Positive Acute Lymphoblastic Leukemia (ALL) and Favorable Presenting Features May Benefit from the Use of Vincristine-Dexamethasone (VCR-DXM) Pulses on Top of Antimetabolite-Based Continuation Therapy. (2005) (4)
Association between a combination of single nucleotide polymorphisms and large vessel cerebral vasculopathy in African children with sickle cell disease. (2016) (4)
Prognostic Value of Minimal Residual Disease Measured By Flow Cytometry in Two Cohorts of Infants with Acute Lymphoblastic Leukemia Treated with MLL-Baby and Interfant Protocols in Large Multicenter Networks (2019) (4)
Genomic Landscape of Pediatric Mixed Phenotype Acute Leukemia (2016) (4)
The role of integrins in IgA nephropathy (1997) (3)
Acute Leukemia of Ambiguous Lineage: A Comprehensive Survival Analysis Enables Designing New Treatment Strategies (2016) (3)
Next‐generation sequencing of PTEN mutations for monitoring minimal residual disease in T‐cell acute lymphoblastic leukemia (2020) (3)
Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia (1994) (3)
Development delays and temperament in children with leukemia after the first year of therapy (2015) (3)
N-acetyl-beta-D-glucosaminidase activity in T chronic lymphocytic leukaemia. (1981) (3)
Li-Fraumeni syndrome: a case report from Italy. (1990) (3)
Hemiasterlin analogues incorporating an aromatic, and heterocyclic type C-terminus: design, synthesis and biological evaluation (2014) (3)
[The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)]. (1994) (3)
Restriction fragment length polymorphism analysis reveals different allele frequency and a linkage disequilibrium at locus D1S94 in neuroblastoma patients. (1997) (3)
ABERRANT GM-CSF SIGNAL TRANSDUCTION PATHWAY IN JUVENILE MYELOMONOCYTIC LEUKEMIA BY FLOW CYTOMETRY: RELIABILITY OF A RETROSPECTIVE STUDY (2010) (3)
Outcome of Early T-Cell Precursor Acute Lymphoblastic Leukemia in AIEOP Patients Treated with the AIEOP-BFM ALL 2000 Study (2014) (3)
Inhibition of NOTCH1 Signaling and Glucocorticoid Therapy in T-ALL (2008) (3)
Centralized cytogenetic analysis of pediatric acute leukemia: results of an Italian collaborative experience. (1997) (3)
The Genomic Landscape of Childhood and Adult Acute Erythroid Leukemia (2016) (3)
Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia (2017) (3)
An International Multi-Center Study To Define the Application of Microarrays in the Diagnosis and Subclassification of Leukemia (MILE Study): Interim Analysis Based on 1,889 Patients Achieves 95.4% Prediction Accuracy. (2006) (3)
Clonal Evolution and Lack of BCR-ABL1 Mutations in Pediatric Ph+ ALL Patients Resistant/Refractory to Imatinib Treatment (2015) (3)
Prognostic Impact of Minimal Residual Disease (MRD) in Children Is Different in B or T Lineage Acute Lymphoblastic Leukemia: Results of Trial AIEOP-BFM ALL 2000. (2007) (3)
Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels. (2009) (2)
The guanine triphosphatase (GTPase) activating protein (GAP)-related domain of the neurofibromatosis type 1 gene is not mutated in neural crest-derived sporadic tumours. (1998) (2)
Treatment Intensification of Traditional BFM Therapy with 3 Chemotherapy Blocks and Double Delayed Intensification (Protocol II) Improves Outcome in Infants with High Risk (HR) Acute Lymphoblastic Leukemia (ALL): Results of Two Consecutive AIEOP Studies. (2005) (2)
FOXO 3 a and Posttranslational Modi fi cations Mediate Glucocorticoid Sensitivity in BALL (2015) (2)
FLT3-ITD: technical approach and characterization of cases with double duplications. (2006) (2)
The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing (2020) (2)
Long‐term results of AIEOP‐8805 protocol for acute B‐cell lymphoblastic leukemia of childhood (2011) (2)
Non-Radiolabelled PCR Consensus Primers and Automatic Sequencing Enable Rapid Identification of Tumor-Specific VH CDR3 in Aggressive B-Cell Malignancies (2003) (2)
Evaluation of Technical Issues in a Pilot Multicenter Newborn Screening Program for Sickle Cell Disease (2018) (2)
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype. (2014) (2)
Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients (2021) (2)
Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin. (1999) (2)
BAG1 down‐regulation increases chemo‐sensitivity of acute lymphoblastic leukaemia cells (2021) (2)
Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia. (2006) (2)
Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL. (2017) (2)
NUP98 Fusion Proteins Are Recurrent Aberrancies in Childhood Acute Myeloid Leukemia: A Report from the AIEOP AML-2001-02 Study Group (2014) (2)
IKZF1 and 22q11.22 Deletions and PDGFRA Gains Are Associated with Poor Outcome in Down Syndrome Acute Lymphoblastic Leukemia (2012) (2)
Childhood Liver Tumour Tissue Storage Programme: a SIOP liver tumour study initiative. (1994) (2)
High Dose Methotrexate (HD MTX at 2 gr/sqm x 4) Associated to Extended Intrathecal (IT) Chemotherapy Is Effective for Prevention of Central Nervous System (CNS) Relapse in Childhood ALL Treated with BFM Systemic Therapy. (2005) (2)
Altered mRNA Expression of Pax-5 Is a Common Event in Acute Lymphoblastic Leukemia. (2008) (2)
Immunological and Molecular Classification of Human Leukemias (1986) (1)
Expression and Role of hERG1 Channels in Pediatric Acute Lymphoblastic Leukemias: Shortcoming of Drug Resistance by hERG1 Channel Inhibitors in Stoma-Supported Leukaemia Cell Cultures In Vitro . (2007) (1)
c-Met Oncogene Enhances Fas-Mediated Apoptosis in B-ALL t(12;21) Cells. (2005) (1)
OUTCOME OF CHILDREN (NON-INFANT) WITH T(4;11) POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH AIEOP-LLA 2000-R2006 PROTOCOLS (2010) (1)
Detection of CALM-AF10 Fusion Transcript Does Not Predict A Poor Prognosis in Children with T-Lineage Acute Lymphoblastic Leukemia Treated with AIEOP ALL 2000 Protocol and Subsequent Modified 2000 Study (R-2006). (2009) (1)
Validation of MRD Quantification By Flow Cytometry for Pediatric BCP ALL Relapsed Patients Treated on the Intreall Protocol (2015) (1)
Genetic and Epigenetic Characterization of a Discordant KMT2A/AFF1-Rearranged Infant Monozygotic Twin Pair (2021) (1)
In Infant ALL with t(4;11)/ MLL-AF4 multiple and phenotypically distinct CD19+ BM subsets initiate leukemia in NOD/SCID mice (2010) (1)
Evolution of Sub-Clones with KRAS Mutations In Pediatric Patients with MLL-AF4 Rearrangements (2011) (1)
Health Locus of Control in Parents of Children with Leukaemia (2017) (1)
Somatic PTPN11 mutations in childhood acute leukemia (2004) (1)
Identification of a monoclonal antibody specific for human T and B lymphocytes (1989) (1)
Acute Lymphoid Leukaemias (ALL) and Minimal Residual Disease in ALL (2018) (1)
Aspergillus flavus Disseminated Infection in Paediatric Acute Lymphoblastic Leukaemia: A Case Report (2017) (1)
Leukemia blast cell identification (2015) (1)
Symmetrical alpha-bromoacryloylamido diaryldienone derivatives as a novel series of antiproliferative agents. Design, synthesis and biological evaluation. (2010) (1)
Prognostic relevance of cell proliferative rapidity in neoplastic hemo-lymphopathology. (1997) (1)
DNA index has prognostic value of LLA in children treated with BFM type intense chemotherapy. Final protocol results AIEOP-LLA-94 (2007) (1)
Methylation of the IL-12Rb2 Gene as Novel Tumor Escape Mechanism for Pediatric B-Acute Lymphoblastic Leukemia Cells (2006) (1)
Reverse Phase Protein Assay (RPPA) Defines Specific Patterns in Childhood Acute Lymphoblastic Leukemia (ALL) (2008) (1)
TEL/AML1 Rearrangement Is Rare in Children with Acute Lymphoblastic Leukemia (ALL) and Down Syndrome (DS). Presenting Features and Treatment Outcome in the Experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). (2007) (1)
High Clonal Evolution Rate in Relapsing Infant ALL Patients. (2004) (1)
Abstract 46: CDK4/CDK6 inhibition in childhood B-ALL: A new strategy to mediate glucocorticoid sensitivity (2017) (1)
Specific Circulating Microvesicles (cMVs) Populations in Paediatric ALL (2011) (1)
Subunit a of Coagulation Factor XIII As a New Biomarker in Childhood Acute Lymphoblastic Leukemia (2014) (1)
Mutational Loss of PTEN Induces Resistance to NOTCH1 Inhibition in T-ALL. (2007) (1)
Paediatric patients cured for leukemia back to school: Analysis of narratives about daily life and illness experience (2018) (1)
Long-Term Outcome of Children with Acute Myeloid Leukemia in First Remission Given Allogeneic HSCT from a Matched Family Donor After a Conditioning Regimen Comprising Busulfan, Cyclophosphamide and Melphalan. (2009) (1)
Rhob Overexpression Boosts Relapse of t(8;21) RUNX1-RUNX1T1 Rearranged Acute Myeloid Leukemia. (2017) (1)
Significance of serial biopsies after renal allograft in children. (1998) (1)
The Immunophenotypic Analysis of Acute Non-Myeloid Leukemias in Infants (1990) (1)
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) (2022) (1)
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to acquire an immunesuppressive phenotype by downregulating CTLA4 (2013) (1)
Gene Expression Profiling in Down Syndrome Acute Lymphoblastic Leukemia Identifies Distinct Profiles Associated with CRLF2 Expression Status. (2009) (1)
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies (2018) (1)
Genomic subtyping and therapeutic targeting of acute erythroleukemia (2019) (1)
Phosphoproteomic profiling of pediatric B-ALL patients with MLL rearrangements (2008) (1)
Genomic Landscape of Acute Erythroid Leukemia (2016) (1)
Abstract 1297: CDK4/CDK6 inhibition in childhood B-acute lymphoblastic leukemia: a new strategy to mediate glucocorticoid sensitivity (2016) (1)
Erratum to: Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery (2014) (1)
Expression of Annexin 2 in Pediatric B-Acute Lymphoblastic Leukemia: A Marker of Aggressiveness and A Potential Therapeutic Target. (2009) (1)
Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (2018) (1)
Prevalence and Clinical Correlates of JAK2 Mutations in Pediatric Down Syndrome Acute Lymphoblastic Leukemia. (2008) (1)
Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). (1994) (1)
Microrna-150 Regulates STAT5b Levels in Juvenile Myelomonocytic Leukemia (JMML) (2015) (1)
Novel Chimeric Transcripts Involving PAX5 in B-Cell Precursor ALL (2013) (1)
Treatment intensification with repeated BFM-protocol II may prevent early relapse in very high risk all AIEOP-ALL 9503 study (1997) (1)
Molecular Characterization of Long Non-Coding RNA CASC15 in Leukemogenesis (2016) (1)
A leucemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of leukemias (2005) (1)
Biological Features and Prognostic Impact of CRLF2 Overexpression In Childhood ALL (2010) (1)
An International Multi-Center Study To Define the Application of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia (MILE Study): Analysis of Completed Stage I with 2030 Patients Achieved a 95.4% Accuracy. (2007) (1)
PTPN11 and RAS Gene Mutation Pattern Identifies an Unique Feature of Upregulated RAS Function in Infant ALL. (2004) (1)
MiR-34b Promoter Methylation and Regulation of CREB Expression In Myeloid Transformation (2010) (1)
Antithrombin Plasma Levels and Fibtem Determination in Children with Acute Lymphoblastic Leukemia Undergoing Asparaginase Treatment (2014) (1)
Dna Methylation Is Linked to a Specific Cell-Adhesion Program in Relapsed Pediatric t(8;21)(q22;q22)RUNX1-RUNX1T1 Patients (2016) (1)
Poor Prognosis for IKZF1 Intra-Gene Deletions in Pediatric Ph– B-Cell Precursor Acute Lymphoblastic Leukemia (2011) (1)
Minimal residual disease monitoring and biological markers for early detection of patients at risk for treatment failure in childhood non-Hodgkin 's lymphomas (2004) (1)
Post-traumatic Stress in Parents of Children with Leukemia: Methodological and Clinical Considerations (2015) (1)
In vitro radiation-induced apoptosi and prediction of radiotherapy response in pediatric tumors. (1998) (1)
Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin. (2008) (1)
FLT3-ITD As a Target for Minimal Residual Disease Monitoring in Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (2014) (1)
LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursors (2019) (1)
Chronic myelomonocytic leukemia (CMML) in childhood. (Abstract) (1994) (1)
Role of DNA index in childhood acute lymphoblastic leukemia treated with BFM based therapy: Long term results of the AIEOP-ALL 95 (2007) (0)
Virulence H. pylori genes cagA and oipA interplay with IL1b and IL1-RN host genes in favoring preneoplastic and neoplastic gastric lesions (2001) (0)
Expression Level Of A Coagulation Factor Gene, F13A1 Defines Characteristic Subpopulations Of Childhood Acute Lymphoblastic Leukemia (2013) (0)
Integrin Alpha M Chain Expression at Diagnosis Is Inversely Correlated with Cytoreduction Rate and Is Consistently Up-Regulated during Therapy in Acute Lymphoblastic Leukemia (ALL) (2008) (0)
Rearrangement of CRLF2 in B-Progenitor and Down Syndrome Associated Acute Lymphoblastic Leukemia. (2009) (0)
Acute Differentiated Dendritic Cell Leukemia: A New Form of Pediatric Acute Myeloid Leukemia (AML) with MLL Translocations. (2005) (0)
MYELOID NEOPLASIA Exome sequencing identi ﬁ es putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome (2013) (0)
Zebrafish Ortholog of Human DOT1L Regulates Primitive and Transient Definitive Hematopoiesis and Controls hoxa9 and meis1 Expression (2012) (0)
Favorable Outcome of Children with Acute Megakaryoblastic Leukemia Treated with the AIEOP AML 2002/01 Protocol (2012) (0)
Characterization of lincRNA BALIR-6 in MLL rearranged B-lymphoblastic leukemia (2013) (0)
Abstract B62: Cell cycle alterations in paired diagnosis-relapse childhood acute lymphoblastic leukemia. (2013) (0)
Lesions and Blood of a Melanoma Patient Metastatic Melan-A/MART-1-Specific CTL in Large and Dissimilar Repertoire of (2013) (0)
Time to Leukemia (TTL) in NOD/SCID Mice Determines Patient Outcome and Is Characterized by a 5 Genes Signature Associated with Relapse (2008) (0)
retroviral and lentiviral vectors Effects of CD2 locus control region sequences on gene expression by (2013) (0)
Expression of CD58 in normal,regenerating and leukemic bone marrow B Cellls: implications for minimal residual disease detection (2003) (0)
A New Subtype of Excellent Prognosis Identified by GEP in Childhood BCP-ALL Patients (2008) (0)
GM-CSF and IL-6 induce tolerogenic myeloid-derived suppressor cells through C/EBP beta and allow long term islet allograft survival (2009) (0)
Three Dimensional Speckle Tracking Echocardiography (3D-STE) for Early Detection of Subtle Myocardial Deformation Dysfunction in Thalassemic Patients (2015) (0)
Lymphocyte phenotype after treatment for leukemia. (1990) (0)
Pharmacological Inhibition of Lck is Able to Revert Glucocorticoid Resistance in Pediatric T-ALL (2016) (0)
Oligoclonal Origin Of Functionally Distinct Leukemic Stem Cells In Infant Acute Lymphoblastic Leukemia (2010) (0)
Poor Prognosis in Children with ABL-Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols (2019) (0)
295 POSTER Growth inhibition and induction of apoptosis in anaplastic large cell lymphoma cells treated with the CDK inhibitor flavopiridol (2008) (0)
The inducible cyclic adenosine 3',5'-monophosphate early repressor (ICER) enhances drug sensitivity in acute myeloid leukemia. (2009) (0)
The necessary North-South co-operation for Sickle Cell Disease: preliminary results of the study of HbS frequency in Guinea-Bissau (2014) (0)
Assessment of therapeutic effects of Notch-1 blockade in T-acute lymphoblastic leukemia xenograft models (2012) (0)
Acute Leukemias New methodologic approaches for immunophenotyping acute leukemias (0)
Human choline kinase a1 in complex with compound 1-[[4-[2-[4-[[4-(dimethylamino)pyridin-1- yl]methyl]phenoxy]ethoxy]phenyl]methyl]-N,N- dimethyl-pyridin-4-amine (compound 10a) (2016) (0)
A Prospective Haematological Survey Of Italian Patients Affected By Shwachman-Diamond Syndrome: Results Of A Ten Years Multicentric Study (2011) (0)
Three-Drug Induction and BFM-Type Intensive Consolidation Chemotherapy for Treatment of Standard Risk Childhood Acute Lymphoblastic Leukemia Defined Also by DNA index. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) Study ALL-9501. (2004) (0)
LincRNA Expression Discriminates Cytogenetic Subtypes In B-Lymphoblastic Leukemia and Plays a Functional Role In Leukemia Cell Survival (2013) (0)
STAT5 Phosphorylation Status by Flow Cytometry Is a Rapid and Reliable Tool for Diagnosis and Follow up of Juvenile Myelomonocytic Leukemia (2010) (0)
Mutational Landscape, Clonal Evolution Patterns and Role of RAS Mutations in Relapsed Acute Lymphoblastic Leukemia (2016) (0)
The Human AF9 Homologue in Zebrafish Is Involved in Primitive Hematopoietic Development. (2009) (0)
Analyses of CREB and ICER expression in acute childhood leukemias. (2006) (0)
Hematopoietic Cell Transplantation for Children with High Risk Acute Lymphoblastic Leukemia in First Complete Remission: A Report From the Italian Association of Pediatric Hematology and Oncology (AIEOP) Registry. (2012) (0)
Induction of Expandable T issue-Specific Stem / Progenitor Cells through Transient Expression of YAP / TAZ Graphical (2016) (0)
Potent in vitro and in vivo effects of EB‐3D, a novel choline‐kinase inhibitor in breast cancer (2016) (0)
HOW MANY CHILDREN WITH THROMBOCYTOSIS OF UNDEFINED ORIGIN HAVE A MYELOPROLIFERATIVE NEOPLASM (2013) (0)
Clinico-Biologic Characterization of 5203 Acute Lymphoblastic Leukemia Patients Enrolled in the Italian Aieop and Gimema Protocols, Stratified in Age-Cohorts From Small Children to Young Elderly (2010) (0)
AKR1C enzymes sustain therapy resistance in paediatric T-ALL (2018) (0)
The Italian hospital-based registry of pediatric cancer: 11 years' experience (2001) (0)
childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study Late MRD response determines relapse risk overall and in subsets of (2013) (0)
Design and synthesis of azolylmethyl-pyrroloquinolines as potent and selective non steroidal CYP19 inhibitors (2013) (0)
Ethnic differences in HbS and G6PD distribution: need for a tailored screening program? (2014) (0)
Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Enrolled In The AIEOP AML 2002/01 Trial: The Impact Of Minimal Residual Disease On Patient Outcome (2013) (0)
Dissecting the molecular regulatory networks in human myeloid-derived suppressor cells (2012) (0)
Prevalence and Prognostic Impact of CEBPA mutations in Children with AML Treated with the AIEOP-LAM 2002/01 Protocol. (2009) (0)
Trisomy of Chromosome 7: a Novel Cytogenetic Abnormality in a Paediatric Case of Mixed Acute Leukemia. (2009) (0)
Characterizing the Function of an RNA Binding Protein, IGF2BP3, in Hematopoiesis (2015) (0)
Abstract C4: TR-764 is a novel tubulin binding agent with strong antiangiogenic activity. (2013) (0)
Minimal Residual Disease Monitoring In Acute Lymphoblastic Leukemia Patients Using Immune Receptor Sequencing (2013) (0)
Wnt pathway activation inhibits Notch pathway in zebrafish xeno-transplanted glioblastoma derived cells (2011) (0)
Hepatitis B virus and primary hepatic tumors in Italian children (1989) (0)
New Therapeutic Opportunities for Pediatric Patients with t(6;11)-Rearranged Acute Myeloid Leukemia (2016) (0)
281 Ten years of a prospective haematological survey of patients affected by Shwachman-Diamond syndrome: Results of an Italian multicentric study (2011) (0)
Children with Thalassemia Major Display Abnormal Renal Tubular Function (2016) (0)
[Cerebral changes shown by computed tomography in children with acute lymphatic leukemia after therapy]. (1983) (0)
Advances in Brief Aloe-emodin Is a New Type of Anticancer Agent with Selective Activity against Neuroectodermal Tumors 1 (2000) (0)
Clonal Profile Analysis of Leukemic Progenitors and Diagnosis Blast Cells in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (2008) (0)
Pancreatic Cancer (PaCa)-Derived Soluble Mediators Induce Dendritic Cells (DC) to Acquire an Immunosuppressive Phenotype by Downregulating CTLA4 (2012) (0)
THE FUSION GENE PAX5/TEL AS A MODEL FOR FUNCTIONAL ALTERATIONS OF THE PAX5 GENE IN PEDIATRIC LAL; IDENTIFICATION OF NEW INJURIES IN AIEOP PATIENTS (2010) (0)
A novel copper(I) induces ER stress-mediated apoptosis in leukemia cell lines (2011) (0)
Glioblastoma-derived cells exhibit differential responses to glycolysis inhibition under hypoxia. (2016) (0)
JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis (2014) (0)
Macrolide Antibiotics By Modulating the Autophagic Flux Exert an Antileukemic Effect through the Involvement of hERG1 Potassium Channel (2016) (0)
targeting of NOTCH3 by miR-150 Modulation of microRNA expression in human T-cell development: (2014) (0)
ZNF521 Is a Zinc Finger Protein That Prevents Differentiation Of Human MLL-AF9-Positive Myeloid Leukemic Cells (2013) (0)
Alterations of Cell Signaling Pathways in Pediatric B-ALL Patients. (2006) (0)
Azolylmethyl-pyrroloquinolines as non steroidal aromatase inhibitors (2013) (0)
Mutational analysis of the NF1 GAP-related domain in neuroectodermal tumors (1994) (0)
treatment of children with acute myeloid leukemia Results of the AIEOP AML 2002/01 multicenter prospective trial for the (2013) (0)
Mosaic Distribution of RAS Pathway Mutated and Non Mutated Cells in Bone Marrow of Juvenile Myelomonocytic Leukemia. (2012) (0)
Multivariate survival analysis of Italian neuroblastoma (NB) patients shows N-myc amplification not to be an independent prognostic factor (1991) (0)
Identification Of Low Risk Group In Infants With Acute Lymphoblastic Leukemia By Flow Cytometric Minimal Residual Disease Measurement At Day 15 Of Interfant-99 and Interfant-06 Protocols Treatment (2013) (0)
Could Hemorrhagic and Thrombotic Risk Due to Peg-Asparaginase be Identified By Coagulative Tests Using Fibtem and Antithrombin Levels? A Single Centre Study (2015) (0)
Gene Expression Profile Analysis of Pediatric MDS Patients Correlates with FAB Classification and Has Prognostic Relevance (2008) (0)
Phosphoproteomic profiling of pediatric B-ALL identifies in mill patients a new signaling pathway for targeted therapy (2008) (0)
Does the reciprocal translocation (11;22) associated with abnormality of 1p identify a distinct entity of neuroectodermal tumor?☆ (1992) (0)
Core Binding Factor Acute Myeloid Leukemia In Pediatric Patients Of The AIEOP AML 2002/01 Trial: Screening and Prognostic Impact Of cKIT Mutations (2013) (0)
How gender influences fibrosis regression in a chronic murine model of hepatic injury (2017) (0)
Gene Expression Profiling Differentiates Childhood Acute Lymphoblastic Leukemia in Down Syndrome Versus Non-Down Syndrome Patients. (2008) (0)
leukemia : results in 3184 patients of the AIEOP-BFM ALL 2000 study children and adolescents with B-cell precursor acute lymphoblastic Molecular response to treatment redefines all prognostic factors in (2010) (0)
The cAMP Response Element Binding Protein (CREB) Overexpression Induces Myeloid Transformation in Zebrafish (2012) (0)
af9 Regulates gata2 Expression During Early Hemangioblast Specification and Vascular Pattern Formation In Zebrafish. (2010) (0)
T-cell Receptor Delta Gene Configuration in Acute Lymphoblastic Leukemia of Infancy (1990) (0)
Life and death of haemocytes of the colonial ascidian Botryllus schlosseri during the blastogenetic cycle (2007) (0)
Prognostic Value of Immunophenotype In Infant ALL – Results of the INTERFANT'99 Study (2010) (0)
HEPATOCELLULAR CARCINOMA IN HBsAg NEGATIVE CHILDREN (1991) (0)
Mitochondrial reactive oxygen species prime T-cell acute lymphoblastic leukemia to cell death by engaging the OMA1-OPA1 axis (2016) (0)
BAG1 Overexpression Restrains the Anti-Apoptotic BCL2, MCL1 and HSP70 Proteins in Acute Myeloid Leukemia. (2012) (0)
CHARACTERIZATION OF HUMAN NON-T ACUTE LYMPHOBLASTIC LEUKAEMIA: RESULTS OF A MULTICENTRE STUDY (1987) (0)
Features of Avascular Osteonecrosis in Children Treated for Acute Lymphoblastic Leukaemia: Experience in a Single Center (2016) (0)
Gender dimorphism in fibrosis dynamics in a murine model of chronic hepatic injury (2018) (0)
Lymphocyte phenotype after treatment for leukemia [letter; comment] (1990) (0)
Refinement of IKZF1 Genomic Status in Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia (2014) (0)
Age-dependent Prognostic Significance of N-myc Copy Number in Neuroblastoma1 (1990) (0)
Title : Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK 2 mutations (2018) (0)
subtype pediatric, cytogenetically normal AML, not restricted to FAB M7 fusion transcript is a novel common feature in CBFA2T3-GLIS2 (2014) (0)
Results of an AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Randomized Clinical Trial in Children with Low- and Intermediate-Risk Relapsed Acute Lymphoblastic Leukemia (ALL) (2014) (0)
CREB Controls C/Ebpd to Impair Myeloid Differentiation Process in Acute Myeloid Leukemia (2015) (0)
Feasibility of Multicentric Assessment of MRD in All by Flow-Cytometry: Standardization and Experience of the I-BFM-ALL FCM-MRD Study Group. (2004) (0)
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia (2022) (0)
Correction to: LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursors (2019) (0)
Pitavastatin, a new HMG-CoA reductase inhibitor, induces phototoxicity in human keratinocytes NCTC-2544 through the formation of benzophenanthridine-like photoproducts (2011) (0)
Microvesicles Transcripts As Hallmark and Vector From Leukemic Parental Cells (2012) (0)
Emerging players in liver fibrosis regression in a chronic murine model of hepatic injury (2017) (0)
RAS activation via CRLF2 signaling is a widespread mechanism in Down syndrome acute lymphoblastic leukemia regardless of RAS mutations (2020) (0)
Wnt signaling promotes phenotypic reprogramming of glioblastoma-derived cells in the zebrafish brain microenvironment (2011) (0)
A case of juvenile myelomonocytic leukemia presenting with a B-lymphoblastic immunophenotype. (2001) (0)
Application of a cDNA microarray for the analysis of muscular dystrophies and childhood leukemias (2003) (0)
CALM-AF10 not an unfavorable prognostic factor in children with acute lineage-t lymphoblastic leukemia (ALL-T) treated with I protocols AIEOP LLA-2000 and LLA-R-2006 (2010) (0)
Abstract B21: Genetic characterization and therapeutic targeting of MYC translocated pediatric T-cell acute lymphoblastic leukemia (2016) (0)
ANDREIA FILIPA MADUREIRA GUIMARÃES VANIN-2, A POTENTIAL PROGNOSTIC MARKER OF RESISTANCE IN ACUTE LYMPHOBLASTIC LEUKEMIA (2015) (0)
Alpha interferon and retinoic acid for the treatment of pediatric neuroendocrine tumors: molecular, preclinical and clinical studies (1996) (0)
Gain of 17q chromosome in a pediatric AML case with 9;11 translocation (1999) (0)
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis (2013) (0)
Gene symbol:ASL. Disease: Argininosuccinate deficiency. (2008) (0)
[Etiologic diagnosis of pneumonia in the immunocompromised child]. (1991) (0)
Extensive Coagulation Profile in Children with Sickle Cell Disease and Its Role in Cerebral Micro-Vasculopathy (2012) (0)
Elevated Level Expression of MiR-223 Is Associated with Worse Prognosis in Childhood T-Cell Lymphoblastic Lymphoma (2016) (0)
Genomic and Transcriptomic Analyses Revealed Differences and Similarities Between T-Lbl and T-ALL. (2009) (0)
Brief Report (2013) (0)
Immunological and cytochemical characterization of normal and neoplastic human T-lymphocytes. (1979) (0)
Identification of new genomic lesions in childhood ALL without known genetic aberrations: A microarray study of gene expression and genotype data. (2006) (0)
LAL infant introduces a new specific genomic profile (2008) (0)
CLINICAL AND BIOLOGICAL FEATURES OF LONG-TERM SURVIVING NEUROBLASTOMA PATIENTS WITH MYCN AMPLIFICATION (1991) (0)
Prognostic Role of Minimal Residual Disease before and after Hematopoietic Stem Cell Transplantation in Childhood Acute Lymphoblastic Leukemia (2015) (0)
A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction (2014) (0)
NOVEL Recurrent Genetic Aberrations in Pediatric AML: An AIEOP AML-2002 Study Group. (2012) (0)
Identification of somatic and germline mutations using whole exome sequencing of congenital acute lymphoblastic leukemia (2013) (0)
CI-FISH, GEP, and SNPs Correlate Genomic Categories with Risk Stratification in Children with T-ALL (2012) (0)
The genetic basis and cell of origin of mixed phenotype acute leukaemia (2018) (0)
Xenografts of Pediatric Acute Lymphoblastic Leukemia Retain the Gene Expression Pattern From the Diagnostic Material They Originated From Over Serial Passages. (2009) (0)
Immunophenotypic and morphological evaluation of MDS: The AIEOP experience with a combined approach (2006) (0)
Evaluation of Minimal Residual Disease As a Surrogate Endpoint for Event Free Survival in Childhood B-Lineage Acute Lymphoblastic Leukemia (2016) (0)
Favourable Outcome in Infants with Acute Myeloid Leukemia Treated with the AIEOP AML 2002/01 Protocol (2012) (0)
LYMPHOID NEOPLASIA Genetic loss of SH2B3 in acute lymphoblastic leukemia (2013) (0)
Gene symbol: ASL. Disease: Argininosuccinate lyase deficiency. (2008) (0)
leukemias with the t(4;11) translocation polymerase chain reaction for diagnosis and monitoring of acute Detection of ALL-1/AF4 fusion transcript by reverse transcription- (2011) (0)
Protein expression profiling of acute lymphoblastic leukemia subclasses. (2002) (0)
Reverse Phase Protein Array (RPPA) of High Risk ALL (2012) (0)
Analyses of the Inducible Cyclic Adenosine 3′,5′-Monophosphate Early Repressor (ICER) and cAMP Response Element Binding Protein (CREB) in HL60 Cells: New Insight Leukemogenesis?. (2006) (0)
GENE EXPRESSION PROFILING INDICATES A DOMINANT NEGATIVE ROLE OF PAX5/TEL ON ENDOGENOUS PAX5 IN PRE-BI CELLS (2010) (0)
Post-traumatic stress symptoms in 223 childhood cancer survivors: incidence, severity and predictive risk factors (2016) (0)
Discovery of a novel class of anti-proliferative pyrrolo[3,2-f]quinolin-9-ones characterized by interfering with both PI3K-Akt-mTOR signalling and microtubule assembling (2012) (0)
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis (2017) (0)
BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma (2018) (0)
directed immunotherapy leukemia during induction treatment: setting the stage for anti-CD20 CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic (2008) (0)
a target molecule for apoptosis induction of leukemic cells CTLA-4 is not restricted to the lymphoid cell lineage and can function as (2013) (0)
BAG-1 IN ACUTE LEUKEMIA: HUNDRED FACES OF A SINGLE PROTEIN (2010) (0)
Zebrafish model to study signaling pathways involved in pancreatic tumour. (2012) (0)
Gene symbol: ASL. Disease: Argininosuccinate lyase deficiency. (2008) (0)
Long-Term Outcome of Relapsed Acute T-Lymphoblastic Leukemia (T-ALL) in Children and Adolescents (2019) (0)
Targeting Metabolic Vulnerabilities and Aberrant Signal Transduction Pathways in Paediatric T‐cell Acute Lymphoblastic Leukaemia (T‐ALL) (2019) (0)
MRD-Detection by Multiparametric Flow Cytometry in Childhood Precursor B-Cell All:Predictive Impact of Early Blast Reduction Kinetics in Peripheral Blood (PB) on MRD-Level in Bone Marrow (BM) at Day 33 of the All-BFM2000 Potocol. (2004) (0)
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia (2017) (0)
Lack of Protein Kinase C Alpha Is Associated with Poor Prognosis in Pediatric T-Lineage Acute Lymphoblastic Leukemia (2011) (0)
Could (Disseminated and Residual) Minimal Disease be a useful prognostic marker in non-Hodgkin paediatric Lymphomas? (2014) (0)
233 POSTER Bortezomib and Flavopiridol combination induces down regulation of Mcl-1, mitochondrial permeabilization and cell death in ALCL cells (2008) (0)
Protein microarray analysis of aberrant signaling pathways in Acute Myeloid Leukemia to predict the patients responsiveness to PI3K/Akt/mTOR inhibitors (2011) (0)
Use of preventive extracorporeal photopheresis before myeloablative conditioning for allogeneic stem cell transplantation in paediatric patients (2010) (0)
Literature abstracts (2004) (0)
A mixed-methods study of the disease experience in hematopoietic stem cell transplantation survivors: the contribution of text analysis (2020) (0)
Hematological and genetic follow-up of 38 italian shwachman-diamond syndrome (SDS) patients (2006) (0)
Abstract LB-211: NUP98-PHF23 is a novel fusion gene in pediatric cytogenetically normal acute myeloid leukemia (2015) (0)
Loss of PTEN in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients: Proteomic and Molecular Characterization (2014) (0)
Clinical and Biological Characterization of Children with FLT3ITD Mutated Acute Myeloid Leukemia (AML): A Report from the AIEOP AML-2002 Study Group (2015) (0)
High Risk Acute Lymphoblastic Leukemia with Rapid NOD/SCID Engraftment Is Characterized by High Protein Expression of CYCLIN B, Beta-CATENIN, ANNEXIN I and Decreased PKC Alpha Activation (2011) (0)
Selective killing of human T-ALL cells: an integrated approach targeting redox homeostasis and the OMA1/OPA1 axis (2018) (0)
Cytogenetic marker for poor prognosis in peripheral neuroepitheliomas (PNET) of children (1996) (0)
New Data on Robustness of Gene Expression Signatures in Leukemia: Comparison of Three Distinct Total RNA Preparation Procedures. (2006) (0)
Prolactin promotes dendritic maturation of CD14+ cells by up-modulating the GM-GSF receptor (1999) (0)
Abstract 1233:In vitroandin vivopharmacological study of EB-3D: a novel choline kinase inhibitor for breast cancer treatment (2016) (0)
Does IGF2BP1 (insulin like growth factor 2 binding protein 1) drive ETV6-RUNX1 positive B-acute lymphoblastic leukemia? (2017) (0)
Clonal Changes Are Frequent in Relapsed TEL-AML1+ ALL and Predominate in Young Children. (2004) (0)
hERG1 channels and is overcome by hERG1 blockers Chemotherapy resistance in acute lymphoblastic leukemia requires (2011) (0)
Characterisation of the immune response in patients with drug induced liver injury (2017) (0)
Long Term Results of the AIEOP-All-95 Trial for Childhood Acute Lymphoblastic Leukemia. An Insight on the Prognostic Value of Dna Index in the Frame of BFM-Based Chemotherapy. (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giuseppe Basso?

Giuseppe Basso is affiliated with the following schools:

Giuseppe Basso's Academic­Influence.com Rankings

Giuseppe Basso's Degrees

Similar Degrees You Can Earn

Why Is Giuseppe Basso Influential?

Giuseppe Basso's Published Works

Published Works

What Schools Are Affiliated With Giuseppe Basso?

Giuseppe Basso's AcademicInfluence.com Rankings